about
The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritisMigrating lymph dendritic cells contain intracellular CD40 that is mobilized to the immunological synapse during interactions with antigen-specific T lymphocytesOn some aspects of the thermodynamic of membrane recycling mediated by fluid phase endocytosis: evaluation of published data and perspectives.Veterinary students' usage and perception of video teaching resources.Vaccination and early protection against non-host-specific Salmonella serotypes in poultry: exploitation of innate immunity and microbial activity.Cross-susceptibility between periodontal disease and type 2 diabetes mellitus: an immunobiological perspective.Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease.Emergency and therapeutic vaccination--is stimulating innate immunity an option?The immune response to parasitic helminths of veterinary importance and its potential manipulation for future vaccine control strategies.Transcriptional modulation by VIP: a rational target against inflammatory disease.Molecular approaches to the diagnosis and monitoring of production diseases in pigs.Rapid protection of gnotobiotic pigs against experimental salmonellosis following induction of polymorphonuclear leukocytes by avirulent Salmonella enterica.Toll-like receptor expression in C3H/HeN and C3H/HeJ mice during Salmonella enterica serovar Typhimurium infectionVIP inhibits P. gingivalis LPS-induced IL-18 and IL-18BPa in monocytes.Vasoactive intestinal peptide (VIP) prevents killing of virulent and phoP mutant Salmonella typhimurium by inhibiting IFN-gamma stimulated NADPH oxidative pathways in murine macrophages.IL-36 receptor is expressed by human blood and intestinal T lymphocytes and is dose-dependently activated via IL-36β and induces CD4+ lymphocyte proliferation.Oral vaccination with a rough attenuated mutant of S. Infantis increases post-wean weight gain and prevents clinical signs of salmonellosis in S. Typhimurium challenged pigs.Vasoactive intestinal peptide (VIP) differentially affects inflammatory immune responses in human monocytes infected with viable Salmonella or stimulated with LPS.IL-36α induces maturation of Th1-inducing human MDDC and synergises with IFN-γ to induce high surface expression of CD14 and CD11c.Inhibited Production of iNOS by Murine J774 Macrophages Occurs via a phoP-Regulated Differential Expression of NFκB and AP-1.Stimulation of gp91 phagocytic oxidase and reactive oxygen species in neutrophils by an avirulent Salmonella enterica serovar infantis strain protects gnotobiotic piglets from lethal challenge with serovar Typhimurium strain F98 without inducing intAnalysis of short-answer question styles versus gender in pre-clinical veterinary education.Immunocytochemical detection of vasoactive intestinal peptide-like and peptide histidine isoleucine-like peptides in the nervous system and the excretory system of adult Nippostrongylus brasiliensis.Dysregulation of JAK/STAT genes by vasoactive intestinal peptide (VIP) in Salmonella-infected monocytes may inhibit its therapeutic potential in human sepsis.Inhibition of IFN-gamma-stimulated proinflammatory cytokines by vasoactive intestinal peptide (VIP) correlates with increased survival of Salmonella enterica serovar typhimurium phoP in murine macrophages.Pivotal advance: vasoactive intestinal peptide inhibits up-regulation of human monocyte TLR2 and TLR4 by LPS and differentiation of monocytes to macrophages.Vasoactive intestinal peptide inhibits the production of Salmonella-induced inflammatory cytokines by human monocytesPrebiotic and probiotic agents enhance antibody-based immune responses to Salmonella Typhimurium infection in pigsThe effect of homogenates and excretory/secretory products of Nippostrongylus brasiliensis and of acetylcholinesterase on the amplitude and frequency of contraction of uninfected rat intestine in vitroUlex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivoVIP Inhibits Porphyromonas gingivalis LPS-induced immune responses in human monocytesMurine cecal patch M cells transport infectious prions in vivoExpression of IL-1Rrp2 by human myelomonocytic cells is unique to DCs and facilitates DC maturation by IL-1F8 and IL-1F9Immunomodulation by vasoactive intestinal peptide is associated with increased survival and growth of Salmonella Typhimurium in miceImmune evasion by Salmonella: exploiting the VPAC1/VIP axis in human monocytesDifferential immune response to Eimeria maxima infection in fast- and slow-growing broiler genotypesDifferential gene response to coccidiosis in modern fast growing and slow growing broiler genotypes
P50
Q28251734-A09B5E6B-ECCB-4109-9952-2581157277FBQ28576243-A4752BD7-E1B7-4319-90AD-676748ECEE55Q33518671-97B4E2FE-42C5-4670-9B31-EAB27EAB8E70Q33789583-2EF7CF68-BF46-4326-B98F-6C0E7DBA7ED0Q36307972-9B7CBDDF-6011-4510-BA4E-3700C37D125AQ36938546-AD9FBD01-CCA9-4FED-BD6E-4CB4E034A286Q37552024-FE9C4599-7A0F-4CE0-94BB-C61F04E905D5Q37947881-DFEBF07C-A1BE-4F76-861E-66206105F15DQ37982292-78E159FE-039F-49AC-B349-08081C9E45BAQ38019158-8AB16870-F739-4DF5-85F8-F241D733B879Q39324692-A86DA531-F1CF-48A4-97E4-E69F9AF126E0Q39741617-A7EBAB07-F5E9-400A-A006-93501FA33192Q39982373-6C9D459F-418B-4251-A176-0A4FC306D1C8Q40089306-E89F227E-E5FC-4BCA-9192-20C9BA93257BQ40194417-E2120837-DEE3-4717-A1C6-5D219A52A1E9Q40642917-9C2129F6-0552-442B-B949-45AE8D755F6AQ40802833-69833D50-EF7E-4DC3-BF2F-15F8796FE2D2Q41091678-999E07A4-AF11-44A0-9AD6-4AF054E7BB7AQ41472705-AF4A06B7-2651-4994-96DD-C736427E17CFQ42049518-6BF08CD1-3895-4EEF-B222-0EC919167691Q42719415-A4BB4C26-E00E-4B64-82CD-084C4715E154Q44428372-A1C390D8-6C8F-4E57-A21E-0AD55554073DQ47897097-29FFF152-28D5-4C5A-BDDD-594B207EEE1AQ49893892-49ABEA35-2589-4FD4-BC83-13165AA6AD9CQ50093615-05B23BEA-EAEB-451F-9335-564AB1F593F2Q54455716-6AF1CEBF-4290-4E2F-AE76-5FE68632BB9AQ59399694-48C25673-96AC-49F6-86F5-1DDCCFFB5E09Q63859436-404C1B56-E44B-4A5E-BD4C-E48E2D37B5B4Q72007141-1DF75D83-32DE-45E0-8A71-0BBFD82DCA76Q74275322-099CAC84-3FC0-4F2C-876A-57ABC97FB03DQ81397887-88C023A4-3420-4AB6-87B4-36003B2E7DD4Q82307243-F0D30A6F-F196-4E3A-BB0B-C69E379AFC56Q82820067-06E989B7-C305-4680-B8A7-64EA080545EDQ92568749-6055FA2F-60BD-451D-8117-E74D404AD2B3Q92593693-4BCB6EB7-5766-47D0-A750-0138563D6E0AQ92964736-AF1E3F7F-66C6-47B7-958C-34F8368D49CBQ93073630-DBBB1133-952B-430F-A333-24E07125DD5F
P50
description
researcher, ORCID id # 0000-0002-2970-308X
@en
wetenschapper
@nl
name
Neil Foster
@ast
Neil Foster
@en
Neil Foster
@es
Neil Foster
@nl
type
label
Neil Foster
@ast
Neil Foster
@en
Neil Foster
@es
Neil Foster
@nl
prefLabel
Neil Foster
@ast
Neil Foster
@en
Neil Foster
@es
Neil Foster
@nl
P106
P1153
12762317200
P31
P496
0000-0002-2970-308X